These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31323788)

  • 1. Inhibition of DNA Repair Mechanisms and Induction of Apoptosis in Triple Negative Breast Cancer Cells Expressing the Human Herpesvirus 6 U94.
    Caccuri F; Sommariva M; Marsico S; Giordano F; Zani A; Giacomini A; Fraefel C; Balsari A; Caruso A
    Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31323788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. U94 of human herpesvirus 6 down-modulates Src, promotes a partial mesenchymal-to-epithelial transition and inhibits tumor cell growth, invasion and metastasis.
    Caccuri F; Ronca R; Laimbacher AS; Berenzi A; Steimberg N; Campilongo F; Mazzuca P; Giacomini A; Mazzoleni G; Benetti A; Caselli E; Presta M; Di Luca D; Fraefel C; Caruso A
    Oncotarget; 2017 Jul; 8(27):44533-44549. PubMed ID: 28562350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human herpesvirus 6 (HHV-6) U94/REP protein inhibits betaherpesvirus replication.
    Caselli E; Bracci A; Galvan M; Boni M; Rotola A; Bergamini C; Cermelli C; Dal Monte P; Gompels UA; Cassai E; Di Luca D
    Virology; 2006 Mar; 346(2):402-14. PubMed ID: 16368124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. U94 alters FN1 and ANGPTL4 gene expression and inhibits tumorigenesis of prostate cancer cell line PC3.
    Ifon ET; Pang AL; Johnson W; Cashman K; Zimmerman S; Muralidhar S; Chan WY; Casey J; Rosenthal LJ
    Cancer Cell Int; 2005 Jun; 5():19. PubMed ID: 15972109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth and molecular interactions of the anti-EGFR antibody cetuximab and the DNA cross-linking agent cisplatin in gefitinib-resistant MDA-MB-468 cells: new prospects in the treatment of triple-negative/basal-like breast cancer.
    Oliveras-Ferraros C; Vazquez-Martin A; López-Bonet E; Martín-Castillo B; Del Barco S; Brunet J; Menendez JA
    Int J Oncol; 2008 Dec; 33(6):1165-76. PubMed ID: 19020749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and validation of novel nitrogen-based chalcone analogs against triple negative breast cancer.
    Elkhalifa D; Siddique AB; Qusa M; Cyprian FS; El Sayed K; Alali F; Al Moustafa AE; Khalil A
    Eur J Med Chem; 2020 Feb; 187():111954. PubMed ID: 31838326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. U94/rep of human herpesvirus 6 inhibits proliferation, invasion, and angiogenesis of glioma.
    Gu B; Li L; Li M; Wang J; Zhang G; Yao K; Wang S
    Cancer Manag Res; 2018; 10():5991-6001. PubMed ID: 30538548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic reprogramming of epithelial mesenchymal transition in triple negative breast cancer cells with DNA methyltransferase and histone deacetylase inhibitors.
    Su Y; Hopfinger NR; Nguyen TD; Pogash TJ; Santucci-Pereira J; Russo J
    J Exp Clin Cancer Res; 2018 Dec; 37(1):314. PubMed ID: 30547810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of TMPRSS4 Enhances Triple-Negative Breast Cancer Cell Radiosensitivity Through Cell Cycle and Cell Apoptosis Process Impairment.
    Assani G; Segbo J; Yu X; Yessoufou A; Xiong Y; Zhou F; Zhou Y
    Asian Pac J Cancer Prev; 2019 Dec; 20(12):3679-3687. PubMed ID: 31870109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells.
    Min A; Im SA; Kim DK; Song SH; Kim HJ; Lee KH; Kim TY; Han SW; Oh DY; Kim TY; O'Connor MJ; Bang YJ
    Breast Cancer Res; 2015 Mar; 17():33. PubMed ID: 25888415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-221/222 activate the Wnt/β-catenin signaling to promote triple-negative breast cancer.
    Liu S; Wang Z; Liu Z; Shi S; Zhang Z; Zhang J; Lin H
    J Mol Cell Biol; 2018 Aug; 10(4):302-315. PubMed ID: 30053090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MELK as a potential target to control cell proliferation in triple-negative breast cancer MDA-MB-231 cells.
    Li G; Yang M; Zuo L; Wang MX
    Oncol Lett; 2018 Jun; 15(6):9934-9940. PubMed ID: 29805690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PLGA-CTAB curcumin nanoparticles: Fabrication, characterization and molecular basis of anticancer activity in triple negative breast cancer cell lines (MDA-MB-231 cells).
    Meena R; Kumar S; Kumar R; Gaharwar US; Rajamani P
    Biomed Pharmacother; 2017 Oct; 94():944-954. PubMed ID: 28810532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor suppressor role of microRNA-1296 in triple-negative breast cancer.
    Phan B; Majid S; Ursu S; de Semir D; Nosrati M; Bezrookove V; Kashani-Sabet M; Dar AA
    Oncotarget; 2016 Apr; 7(15):19519-30. PubMed ID: 26799586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of human herpesvirus 6A/B U94 as ATPase, helicase, exonuclease and DNA-binding proteins.
    Trempe F; Gravel A; Dubuc I; Wallaschek N; Collin V; Gilbert-Girard S; Morissette G; Kaufer BB; Flamand L
    Nucleic Acids Res; 2015 Jul; 43(12):6084-98. PubMed ID: 25999342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deciphering the molecular mechanism underlying anticancer activity of coumestrol in triple-negative breast cancer cells.
    Zafar A; Singh S; Satija YK; Saluja D; Naseem I
    Toxicol In Vitro; 2018 Feb; 46():19-28. PubMed ID: 28986287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.
    Andey T; Sudhakar G; Marepally S; Patel A; Banerjee R; Singh M
    Mol Pharm; 2015 Apr; 12(4):1105-20. PubMed ID: 25661724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inorganic Phosphate Prevents Erk1/2 and Stat3 Activation and Improves Sensitivity to Doxorubicin of MDA-MB-231 Breast Cancer Cells.
    Sapio L; Sorvillo L; Illiano M; Chiosi E; Spina A; Naviglio S
    Molecules; 2015 Sep; 20(9):15910-28. PubMed ID: 26340617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different mechanisms involved in the berberine-induced antiproliferation effects in triple-negative breast cancer cell lines.
    Lin YS; Chiu YC; Tsai YH; Tsai YF; Wang JY; Tseng LM; Chiu JH
    J Cell Biochem; 2019 Aug; 120(8):13531-13544. PubMed ID: 30957305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel orally available seleno-purine molecule suppresses triple-negative breast cancer cell proliferation and progression to metastasis by inducing cytostatic autophagy.
    Chang CH; Bijian K; Wernic D; Su J; da Silva SD; Yu H; Qiu D; Asslan M; Alaoui-Jamali MA
    Autophagy; 2019 Aug; 15(8):1376-1390. PubMed ID: 30773992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.